gonorrhoea for 14 December 2025

Gonorrhoea Latest News

The U.S. Food and Drug Administration (FDA) recently granted approval for two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhoea, a common sexually transmitted infection, prone to resistance against drugs.

About Gonorrhoea

• It is a preventable and curable sexually transmitted infection (STI) caused by the bacteria Neisseria gonorrhea. 
• It’s also sometimes called “the clap” or “drip.” 
• Gonorrhea bacteria can infect the urethra, rectum, female reproductive tract, mouth, throat, or eyes.
• Transmission: 
  • It is most commonly spread during vaginal, oral or anal sexual activity. 
  • But babies can get the infection during childbirth. 
• In babies, gonorrhea most commonly affects the eyes.
• Gonorrhea can affect people of any age, anatomy, or gender, but it’s particularly common among teens and young adults between the ages of 15 and 24.
• Symptoms: 
  • Many people with gonorrhoea won’t notice any symptoms. If you do get symptoms, it’s usually between 1 to 14 days after getting the infection.
  • Men are more likely to experience symptoms. Up to 50% of women won’t experience symptoms. 
  • Gonorrhoea can cause a sore throat, conjunctivitis, unusual vaginal or penile discharge, and pelvic and genital pain.
• Untreated gonorrhoea can cause:
  • infections affecting the skin, joints, heart (endocarditis), and brain (meningitis)
  • infertility in both females and males
  • pelvic inflammatory disease (PID)
  • epididymitis and prostatitis (inflammation of your prostate)
  • Some of these complications can cause permanent damage to your health.
• Prevention: It can be prevented by practicing safe sex.
• Treatment: 
• Gonorrhoea is treatable and curable with antibiotics.
• Antimicrobial resistance to gonorrhoea is a serious and growing problem, rendering many classes of antibiotics ineffective with the risk of becoming untreatable.

Source: TH